| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | Orville Jacob A76 | General Manager, New Ventures | Sale+OE | 1,033 | $142.66 | $147,367.78 | -22.8% | |
| Feb 17, 2021 | Lidgard Graham Peter | Chief Science Officer | Sale+OE | 2,131 | $142.66 | $304,008.46 | -5.6% | |
| Feb 17, 2021 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 2,020 | $142.66 | $288,173.20 | -4.8% | |
| Feb 17, 2021 | Coward D Scott77 | Chief Administrative Officer | Sale+OE | 1,992 | $142.66 | $284,178.72 | -37.8% | |
| Feb 17, 2021 | Conroy Kevin T81 | President And CEO | Sale+OE | 15,825 | $142.66 | $2,257,594.50 | -2.0% | |
| Feb 1, 2021 | Conroy Kevin T81 | President And CEO | Sell | 30,344 | $138.07 | $4,189,596.08 | -3.8% | |
| Jan 4, 2021 | Conroy Kevin T81 | President And CEO | Sell | 31,814 | $128.74 | $4,095,734.36 | -3.7% | |
| Dec 14, 2020 | Zanotti Katherine S50 | Director | Sell | 20,000 | $132.06 | $2,641,182.32 | -14.8% | |
| Dec 1, 2020 | Conroy Kevin T81 | President And CEO | Sell | 30,577 | $124.56 | $3,808,660.42 | -0.5% | |
| Nov 2, 2020 | Conroy Kevin T81 | President And CEO | Sell | 32,819 | $121.11 | $3,974,738.09 | -0.5% |